• INNOVATION LABS //
  • Marketing Resource Directory //
  • Programmatic Power Players //
  • Membership
  • Log in
AdExchanger Homepage
  • Log in
  • COVID-19 Special Coverage
  • Topics
    • Advertiser
    • Publishers
    • Content Studio
    • Platforms
    • Mobile / Cross-Device
    • Data
    • Commerce
    • Investment
    • Agencies
    • TV and Video
    • Politics
  • Opinion
    • Data-Driven Thinking
    • The Sell Sider
    • On TV and Video
    • Brand Aware
    • Content Studio
    • Comic Strip
  • Become A Member
    • Sign Up
  • Events
    • Innovation Labs
    • PROGRAMMATIC I/O NY
    • AdExchanger Awards
    • All Events
  • Podcasts
    • AdExchanger Talks
    • The Big Story
    • Industry Preview
    • Social Distancing With Friends
  • About Us
    • Advertise
    • About Us
    • Contact Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS

  • AdExchanger Homepage

  • AdExchanger.com

  • Menu
    • Advertiser
    • Publishers
    • Content Studio
    • Platforms
    • Mobile / Cross-Device
    • Data
    • Commerce
    • Investment
    • Agencies
    • TV and Video
    • Politics
    • Data-Driven Thinking
    • The Sell Sider
    • On TV and Video
    • Brand Aware
    • Content Studio
    • Comic Strip
    • Advertise
    • About Us
    • Contact Us
  • Events
    • Innovation Labs
    • PROGRAMMATIC I/O NY
    • AdExchanger Awards
    • All Events
  • Podcast
    • AdExchanger Talks
    • The Big Story
    • Industry Preview
    • Social Distancing With Friends
  • Membership
    • Member Exclusives
    • Sign Up
  • Search
Connect

»Pharma

Magna Predicts Faster Than Expected Rebound, With 2021 Ad Spend Set To Hit $240B

Magna’s US ad spend forecast released Wednesday paints an optimistic picture for the ad industry, following the uncertainty caused by the COVID-19 pandemic. The IPG agency said that a quicker than anticipated economic recovery, supported by a new stimulus package, a decline in COVID rates and return to normal sporting events, will boost ad spending... Continue reading »
by Tony Rifilato // March 31st, 2021 //
»
Living in a Cookie-less World: What Other Industries Can Learn From Pharmaceutical Marketers

“Data-Driven Thinking” is written by members of the media community and contains fresh ideas on the digital revolution in media. Today’s column is written by Mark Sturino, VP of data and analytics, at Good Apple. The “death of the cookie” provides an opportunity for all brands to learn from pharmaceutical marketers and leverage new AI... Continue reading »
by AdExchanger Guest Columnist // March 30th, 2021 //
»
For Health Care Brands, Getting To Doctors Is Good For What Ails Them

Every year competition goes up for the limited number of medical residencies in the United States. But that’s nothing compared to marketers’ intensifying race to reach those doctors in the field. While HIPAA’s data privacy regulations have slowed the adoption of programmatic and data-driven marketing around advertising to consumers, companies can still target medical professionals,... Continue reading »
by James Hercher // May 10th, 2017 //
»
 

Popular today on AdExchanger

  • Popular
  • Today Week Month All
  • IOS 14.5 – And ATT Enforcement – Is Finally Coming Next Week
  • Let's Give Walled Gardens The Name They Deserve: Roach Motels
  • For “Cookieless” Solutions to Work, We Need to Talk About Addressability
  • Heineken USA Launches First-Party Data Strategy To Prepare For A Cookieless Future
  • Hive Raises $85 Million For Contextual And Branded Content AI
Ajax spinner
AdExchanger Homepage
  • Privacy Policy //
  • Subscribe //
  • Advertise //
  • Contact Us //
  • Diversity Inclusion & Equity
© 2021 Access Intelligence, LLC - All Rights Reserved